ReviewPhysiological reports2025
Integrated mechanisms linking sodium-potassium imbalance to salt-sensitive hypertension.
Review in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated mechanisms linking sodium-potassium imbalance to salt-sensitive hypertension.Physiological reports · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salt-sensitive hypertension (SS-HT) represents a clinically heterogeneous and mechanistically distinct phenotype of blood pressure dysregulation in which sodium intake disproportionately elevates blood pressure. SS-HT affects up to 50%-60% of individuals with hypertension globally, with an even greater burden among individuals of African ancestry, postmenopausal women, and those with obesity or metabolic syndrome. SS-HT arises from multifactorial dysregulation of renal, vascular, and immune systems. Central to its pathophysiology is aberrant activation of the epithelial sodium channel (ENaC), which drives sodium reabsorption in the distal nephron. ENaC activity is enhanced by both aldosterone-dependent and -independent mechanisms. Concurrently, high dietary sodium induces oxidative stress through NADPH oxidase-mediated reactive oxygen species (ROS) production, disrupts nitric oxide (NO) signaling, and activates antigen-presenting dendritic cells, triggering T-cell-mediated vascular and renal inflammation. This review proposes a systems-level framework in which SS-HT reflects the convergence of ENaC hyperactivation, immunometabolic priming, and hormonal modulation, shaped by sex, race, and dietary sodium-potassium imbalances. Understanding SS-HT as a multifaceted systems disorder opens new avenues for personalized prevention and treatment. Population-specific interventions, such as ENaC-targeting therapies, potassium-enriched diets, and sex and ancestry-informed modulation of the renin-angiotensin-aldosterone system (RAAS), represent promising strategies for precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.